Acessibilidade / Reportar erro

A simplified protocol for evaluating and monitoring urethral stricture patients minimizes cost without compromising patient outcome

UROLOGICAL SURVEY

Reconstructive Urology

A simplified protocol for evaluating and monitoring urethral stricture patients minimizes cost without compromising patient outcome

Okorie CO, Pisters LL, Ndasi HT, Fekadu A

Pan-African Academy of Christian Surgeons at Banso Baptist Hospital, Kumbo, NWP, Cameroon

Trop Doct. 2010; 40: 134-7

Abstract: Uroflowmetry, urethrocystoscopy and urethrography are either not readily available or the cost is prohibitive for many patients in low-resource countries. This paper examines the use of clinical history in post-urethroplasty follow-up. We retrospectively reviewed the outcome of 54 post-urethroplasty patients. Preoperative diagnostic work-up included simple blood tests and a retrograde urethrography, and postoperatively we did not perform any immediate diagnostic work-up. Follow-up of these patients was done through mobile phone calls and personal contacts. Eighty-nine per cent of our patients reported acceptable voiding over a mean follow-up period of 48.4 months - 79.6% were followed using mobile phone contact. In the majority of the urethral strictures cases, diagnostic work up can be kept to a minimum, thereby reducing cost. Follow-up can be done via phone calls and personal contact in many African countries where compliance is frequently less than encouraging. The spread of mobile phone networks across the continent has been remarkable.

Editorial Comment

The study by Erickson et al. seeks to arrive at a non-invasive means of predicting urethral stricture recurrence after urethroplasty. Uroflowmetry is attractive in that it is an objective test. The authors state that maximum urinary flow rate is not by itself a very good predictor of failure but that the combination of maximum flow rate, voiding pattern and urinary obstructive symptoms is predictive. Indeed, the combination of these three factors was the most predictive of a man having a recurrence (PPV 90%); yet this combination misses half the strictures (sensitivity 51%). This low sensitivity means few physicians would be inclined to forgo more invasive testing in any man. Although it was the goal of the authors to find a predictive tool, what would be more helpful to the patient would be a screening tool. A good screening tool helps a portion of the population avoid advanced confirmatory testing, while still preserving high sensitivity. With the latter goal in mind, a high threshold for maximum urinary flow rate (< 20 cc/sec) has excellent sensitivity (92%) and NPV (96%), meaning that it captures 92% of strictures and only misses 4%. While PPV is low (48%) this is acceptable as a screening tool - it just means that a little more than half of men who undergo RUG/VCUG will have no recurrent stricture. At the same time, more than half of the population in this study could avoid a RUG/VCUG because their flow rates were over 20 cc/sec - this is the proper role of a screening tool.

The goal of identifying a useful screening tool for urethral stricture recurrence is echoed in the second article, by Okorie et al. They describe using mobile phones to survey urinary symptoms after urethral stricture treatment. Although the symptoms reported over the telephone were not validated objectively, the concept of telephone follow-up is important, especially in areas of the world where travel to a referral center is difficult. Others have previously shown that home measurement of timed urinary flow correlates well with office-measured maximum urinary flow rate (1). If we were able to validate a means of screening patients over the telephone with timed urinary flow rates with or without telephone-administered validated questionnaires we could spare many patients the travel to a referral center for continued follow-up.

Dr. Sean P. Elliott

Department of Urology Surgery

University of Minnesota

Minneapolis, Minnesota, USA

E-mail: selliott@umn.edu

  • 1. Bloom DA, Foster WD, McLeod DG, Mittemeyer BT, Stutzman RE: Cost-effective uroflowmetry in men. J Urol. 1985; 133: 421-4.

Publication Dates

  • Publication in this collection
    06 Dec 2010
  • Date of issue
    Oct 2010
Sociedade Brasileira de Urologia Rua Bambina, 153, 22251-050 Rio de Janeiro RJ Brazil, Tel. +55 21 2539-6787, Fax: +55 21 2246-4088 - Rio de Janeiro - RJ - Brazil
E-mail: brazjurol@brazjurol.com.br